VECTALYS has a total of 24 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are TOOLGEN INC, SIRION BIOTECH GMBH and CARIBOU BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | France | 3 | |
#5 | Israel | 3 | |
#6 | Hong Kong | 2 | |
#7 | Singapore | 2 | |
#8 | United States | 2 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Bouille Pascale | 15 |
#2 | Gayon Regis | 10 |
#3 | Gayon Régis | 7 |
#4 | Pages Jean-Christophe | 6 |
#5 | Iche Alexandra | 5 |
#6 | Lamouroux Lucille | 4 |
#7 | Vergnault Helene | 3 |
#8 | Bouillé Pascale | 3 |
#9 | Iché Alexandra | 3 |
#10 | Moal Yohann | 3 |
Publication | Filing date | Title |
---|---|---|
WO2017194902A2 | Particle for the encapsidation of a genome engineering system | |
US2018135025A1 | Retroviral particle comprising at least two encapsidated nonviral rnas | |
FR3051197A1 | Viral particle for the transfer of arns in the cells involved in the immune response | |
FR3051196A1 | Particle for the encapsidation of a genome engineering system | |
FR3036118A1 | Retroviral particle comprising at least two encapsid non-viral rna | |
CA2878898A1 | Method for detecting or measuring the impact of a viral vector composition on eukaryotic cells and biomarkers used thereof | |
WO2013014537A1 | Virus-based vector compositions useful for transducing eukaryotic cells |